Blocking an enzyme combats disease

From Orlando, Fla., at a meeting of the American Diabetes Association

Scientists have extended the life of a compound important for metabolism by obstructing an enzyme that breaks it down. Called glucagon-like peptide 1 (GLP1), the beneficial compound stimulates the release of insulin from the pancreas and maintains insulin-making beta cells housed in that organ.